National Human Genome Research Institute (NHGRI)’s Post

Multiomics can enable a deeper understanding of molecular changes impacting cellular responses and disease development. Download SelectScience®’s infographic to learn more and find out how our COMET™ technology can revolutionize your spatial #multiomics studies: https://lnkd.in/eNJ7ehRe

Interesting in learning more about how Multiomics can enable deeper understanding of molecular changes impacting cellular responses & disease development? Check out this great infographic to learn more! https://lnkd.in/eNJ7ehRe

Today is World Sickle Cell Day, a condition impacting over 100,000 individuals in the U.S. In 2022, we spoke with Dr. Lanetta Bronte-Hall, President and founder of Foundation for Sickle Cell Disease Research (FSCDR), to gain insights into this rare disease and the individuals it affects. ❤️ 🧬 Watch the full episode on TheBalancingAct.com/rare #BehindTheMystery #SickleCell #SickleCellDisease #SCDawareness #RareDisease #RareDiseaseAwareness

Our new website features 14 research area pages that detail how our researchers are utilizing #StemCells to better understand our fundamental biology and transform disease treatment. Explore here: https://lnkd.in/gpthJUKU

Our paper on γδ T cells in IBD, which points to a protective role for BTNL regulated γδ T cells in disease, is out now in Science Magazine https://lnkd.in/eg5tVgfV

How can complex innovative designs, meta-analytic predictive models and new statistical approaches help overcome the unique challenges of rare disease clinical trials? Download our white paper to explore groundbreaking strategies to accelerate the path to effective rare disease treatments: https://ow.ly/ijvX30sCYYo #SyneosHealth

How can complex innovative designs, meta-analytic predictive models and new statistical approaches help overcome the unique challenges of rare disease clinical trials? Download our white paper to explore groundbreaking strategies to accelerate the path to effective rare disease treatments: https://ow.ly/YUA730sCYTO #SyneosHealth

Global Impact: UHN-led study decodes rare liver disease, with patients driving the research. Explore the first-of-its-kind insights into PSC, bringing rare diseases to the forefront. Patient power, collaboration and #openscience in action! #PSCBreakthrough #PatientDrivenResearch #RareDisease Read more → https://bit.ly/3H9S76j

A new #COVID19 pub from @UUtah researchers! Check it out: A Linguistic Analysis Examining the Impact of COVID-19 on Pneumonia Diagnosis and Disease Models https://lnkd.in/gtyZTdrm @UofUResearch